COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #97
Source   PDF   Share   Tweet
See all 143 studies
Late treatment study
Lopez et al., Int. J. Antimicrob. Agents, doi:/j.ijantimicag.2020.106136 (Peer Reviewed)
Effects of Hydroxych loroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results
Small retrospective study of 29 ICU patients comparing those with HC Q plasma concentration within target to those with a concentration below the target value, with no significant differences found. Mortality in the on-target group was 0% versus 17% for the off-target group, mortality relative risk 0.14, p = 0.16.
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.